Home › Obesity › New Hampshire

Pag-aaral pangklinika para sa Obesity sa New Hampshire

3 pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa mga site sa New Hampshire.

Opisyal na teksto ng pag-aaral (English)

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Dartmouth-Hitchcock Medical Center, Lebanon

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Dartmouth-Hitchcock Medical Center, Lebanon

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Stracskin, Portsmouth

Nagre-recruitPhase 4

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06857942

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.